Start with our peptide therapy overview, then book a consult to build a protocol that matches your body, your training, and your timeline
Tirzepatide is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should not be used during pregnancy due to potential fetal harm
Cagrilintide Dosage with Retatrutide Retatrutide represents another emerging peptide with GIP, GLP-1, and glucagon receptor activity
A competitive binding method to quantify the displacement of iodinated GLP-1 and GIP radioligands to their cognate receptors was performed as described in ref
Generally, this peptidetends to be competitively priced compared to other therapeutic peptides
Getting the reconstitution and dose right matters, but it is only one piece of the picture